FindTrial
Sign In

Comparison of Smart Scope AI test with cytology test for single visit cervical cancer screening.

Non-Inferiority of the AI-enabled Smart Scope Test Versus Cytology in Cervical Cancer Screening: A Multicentric Observational Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/103860
Enrollment
4400
Registered
2026-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Colposcopy: Women positive on cytology or SS-AI screening test will undergo a colposcopy. During the examination, the colposcopist will assign a Swede score. Women with a Swede score of

Sponsors

Nasscom Foundation
Lead Sponsor
Periwinkle Technologies Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Non-Pregnant, Non-menstruating at the time of screening

Exclusion criteria

Exclusion criteria: Women treated for CIN/Cervical cancer, undergone hysterectomy, not willing for follow up, who don t give written consent.

Design outcomes

Primary

MeasureTime frame
Comparison of AI-enabled Smart Scope test (SS-AI) with the conventional cytology testTimepoint: 15 to 18 months—

Secondary

MeasureTime frame
Accuracy of SS-AI assessment compared to gold standard histopathologyTimepoint: 15 to 18 months;Accuracy of cytology assessment compared to gold standard histopathology Timepoint: 15 to 18 months—

Countries

India

Contacts

Public ContactDr Saritha Shamsunder

VMMC and Safdarjung Hospital

shamsundersaritha@gmail.com9313826748

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026